These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 19724022

  • 1. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade HJ, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
    [Abstract] [Full Text] [Related]

  • 2. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
    Ducheix S, Podechard N, Lasserre F, Polizzi A, Pommier A, Murzilli S, Di Lisio C, D'Amore S, Bertrand-Michel J, Montagner A, Pineau T, Loiseau N, Lobaccaro JM, Martin PG, Guillou H.
    Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y, Duan Y, Yang X, Sun L, Liu M, Wang Q, Ma X, Zhang W, Li X, Hu W, Miao RQ, Xiang R, Hajjar DP, Han J.
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [Abstract] [Full Text] [Related]

  • 6. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M, Bu L, Ma Y, Liu D.
    PLoS One; 2013 Apr; 8(6):e65641. PubMed ID: 23762402
    [Abstract] [Full Text] [Related]

  • 7. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM, Gang GT, Kim DK, Kim YD, Koo SH, Lee CH, Choi HS.
    J Biol Chem; 2014 Jan 10; 289(2):1079-91. PubMed ID: 24265317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation.
    Hijmans BS, Tiemann CA, Grefhorst A, Boesjes M, van Dijk TH, Tietge UJ, Kuipers F, van Riel NA, Groen AK, Oosterveer MH.
    FASEB J; 2015 Apr 10; 29(4):1153-64. PubMed ID: 25477282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S, Shima A, Hiroshima A, Koieyama T, Terasaka N.
    Biochim Biophys Acta; 2011 Dec 10; 1811(12):1136-45. PubMed ID: 21875689
    [Abstract] [Full Text] [Related]

  • 12. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
    Wu J, Wang C, Li S, Li S, Wang W, Li J, Chi Y, Yang H, Kong X, Zhou Y, Dong C, Wang F, Xu G, Yang J, Gustafsson JÅ, Guan Y.
    Hepatology; 2013 Aug 10; 58(2):617-28. PubMed ID: 23348573
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.
    Pharmacology; 2010 Aug 10; 86(5-6):306-12. PubMed ID: 21071998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
    Gao M, Liu D.
    AAPS J; 2013 Jul 10; 15(3):744-52. PubMed ID: 23591747
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG.
    Antioxid Redox Signal; 2011 Oct 15; 15(8):2135-46. PubMed ID: 21504366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
    Zheng F, Zhang S, Lu W, Wu F, Yin X, Yu D, Pan Q, Li H.
    PLoS One; 2014 Oct 15; 9(6):e101269. PubMed ID: 24972069
    [Abstract] [Full Text] [Related]

  • 20. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.
    Ogihara T, Chuang JC, Vestermark GL, Garmey JC, Ketchum RJ, Huang X, Brayman KL, Thorner MO, Repa JJ, Mirmira RG, Evans-Molina C.
    J Biol Chem; 2010 Feb 19; 285(8):5392-404. PubMed ID: 20007976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.